Compare Cronos Group Inc (CRON) vs Cenovus Energy Inc (CVE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Cenovus Energy Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.20B), while Cenovus Energy Inc trades at $31.49 (market cap $56.66B). The key difference: Cenovus Energy Inc is far larger — about 47.2× Cronos Group Inc's market cap, and Cenovus Energy Inc pays a 2.03% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Cenovus Energy Inc for 46 Days on average.
| CRON | CVE | |
|---|---|---|
Market Cap | $1.20B | $56.66B |
Volume | 450,387 | 7,667,753 |
Sector | Health | Energy |
52-Week High | $3.55 | $33.92 |
52-Week Low | $2.30 | $15.85 |
Typical Hold Time | 22 Days | 46 Days |
Enterprise Value | $401.73M | $62.61B |
Dividend Yield | — | 2.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 1.98% on the day, amid a bearish technical signal. The company reported mixed quarterly earnings but achieved record revenue and gross profit in Q2 2026, with net income turning positive. Recent investor day highlighted international expansion and cash flow focus. Valuation ratios show a P/E of 17.11 and P/S of 6.91, with strong net income margin of 39.08% projected for 2026.
Outlook is cautiously optimistic, driven by revenue growth and profitability improvements, but risks include cash flow volatility and competitive pressures. Analyst consensus is mixed with 60% hold rating. The stock's near-term performance hinges on execution of expansion plans and sustained earnings momentum.
Cenovus Energy (CVE) trades at $31.49, up 0.8% today, with a bearish technical signal but strong fundamentals including a P/E of 12.14 and net income margin of 11.48%. Recent earnings beat expectations in Q4 2025 and Q1 2026, while Q2 2026 met estimates. Cash flow from operations remains robust at $8.23B in 2025, though net cash flow was negative due to high capital expenditures. The stock is near its pivot point of $31, with support at $30 and resistance at $32.
Outlook: CVE offers value with attractive valuation ratios and solid profitability, but faces headwinds from volatile oil prices and capital-intensive operations. Analyst consensus is mixed with 40.7% buy ratings, suggesting cautious optimism amid energy sector uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Cenovus Energy Inc
Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →
